Search filters

List of works by Ivan Sloma

Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)

scientific article published in PLoS ONE

Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression

scientific article published on 4 November 2014

Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia

scientific article published on 07 July 2016

Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene

scientific article published on July 16, 2012

Genotypic and functional diversity of phenotypically defined primitive hematopoietic cells in patients with chronic myeloid leukemia.

scientific article published on 11 July 2013

HLA-E*0101 allele in homozygous state favors severe bacterial infections in sickle cell anemia

scientific article published on 19 September 2007

Haemophagocytic histiocyte in a peripheral blood film.

scientific article

Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation

scientific article published on 5 May 2016

Regulation of MHC II and CD1 antigen presentation: from ubiquity to security.

scientific article published on 22 September 2008

Success of interferon α therapy in a patient with hepatitis C virus-negative splenic marginal zone lymphoma associated with polycythemia vera

scientific article published on 2 February 2015

TEL me all

scientific article published on 01 July 2009

Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex

scientific article published on 27 February 2013

Tuberculosis in adult patients with sickle cell disease

scientific article published on 22 August 2007

Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia.

scientific article published on 7 June 2017